External traditional Chinese medicine for preventing and treating COVID-19 and preparation method of external traditional Chinese medicine

Abstract

The invention discloses an external traditional Chinese medicine for preventing and treating COVID-19 and a preparation method of the external traditional Chinese medicine. The external traditional Chinese medicine comprises 25-30g of celandine, 25-30g of Melothria heterophylla, 25-30g of galium aparine, 25-30g of flos cleistocalycis, 25-30g of Nauclea officinalis, 25-30g of Drymoglossum subcordatum Fee, 25-30 g of adiantum capillus-veneris, 25-30 g of Adiantum flabellulatum, 25-30 g of Chinese wolfberry, 25-30 g of fructus forsythiae, 25-30 g of herba andrographitis, 25-30 g of Indian damnacanthus herb, 25-30 g of glechoma longituba, 25-30 g of radix scutellariae, 25-30 g of pyrrosia lingua, 25-30 g of honeysuckle, 25-30 g of rheum officinale, 25-30 g of Shuanghuanglian, 25-30 g of flos chrysanthemi indici, 25-30 g of herba lobeliae chinensis, 25-30 g of gypsum, 25-30 g of Aster ageratoides and 25-30 g of trollflower. The invention further discloses a preparation method of the external traditional Chinese medicine for preventing and treating COVID-19. The external traditional Chinese medicine for preventing and treating COVID-19 is a pure traditional Chinese medicine preparation and is an external medicine, a patient can use the external traditional Chinese medicine at home by himself / herself, an external shower mode is adopted, and the method is simple, convenient, free of toxic and side effects and suitable for application and popularization.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to an external Chinese medicine for preventing and treating new coronary pneumonia and a preparation method thereof. Background technique [0002] The main symptoms of novel coronavirus pneumonia are fever, cough, dyspnea, fatigue, muscle aches, etc. The antiviral drugs ribavirin, lopinavir, interferon and glucocorticoids that have been included in the national version of the diagnosis and treatment plan, as well as remdesivir, are all internal medicines. [0003] At present, there is no specific drug for the treatment of the new coronavirus. The main products and characteristics of the treatment of new coronary pneumonia on the market are as follows: [0004] 1. Antiviral drugs: α-interferon, lopinavir, ritonavir, ribavirin, chloroquine phosphate, arbidol, ribavirin, etc. These drugs have many adverse reactions; [0005] 2. Antibacterial drugs: all kinds of antibacterial drugs h...

AI Technical Summary

Problems solved by technology

[0005] 2. Antibacterial drugs: all kinds of antibacterial drugs have many adverse reactions and limited effects;

[0006] 3. Hormones: mainly high-dose glucocorticoids, with many adverse reactions

[0007] 4. Traditional Chinese medicine treatment: Huoxiang Zhengqi Pills, Shuanghuanglian Oral Liquid and Lianhua Qingwen Capsules, mainly for combined treatment, the effect of single use is limited

[0008] The main therapeutic drugs on the market have shortcomings such as limited effects or many adverse reactions

Images